Imidazole Antimicrobial via Ionic Liquid Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, as conventional antibiotics face increasing resistance, and existing methods for synthesizing organic compounds often involve hazardous solvents and inefficient processes.
Innovation Solution
The synthesis of 4,5-bis(4-bromophenyl)-1-hexyl-2-(3-pyridyl)-1H-imidazole via a one-pot four-component reaction using 4,4′-dibromobenzil, hexylamine, 3-pyridinecarboxaldehyde, and ammonium acetate in pyridinium hydrogen sulfate, which demonstrates excellent antimicrobial activity against various microbes, including gram-positive and gram-negative bacteria, and fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional synthesis methods are used, then chemical transformations can be achieved, but hazardous solvents and volatile organic compounds are generated, increasing environmental harm
Solution Approach 1:
The patent changes the reaction parameters by employing ionic liquids as solvents instead of conventional volatile organic solvents. This parameter change maintains synthesis efficiency while eliminating hazardous VOC emissions, aligning with green chemistry principles
Solution Approach 2:
The patent converts the previously harmful volatile organic solvents into beneficial ionic liquid solvents that are non-volatile and environmentally friendly. The ionic liquids provide similar dissolution capabilities without the harmful VOC emissions, turning a harmful factor into a beneficial one
2Reliability
If conventional antibiotics are used, then bacterial infections can be treated, but bacterial resistance increases, reducing treatment effectiveness
Solution Approach 1:
The patent develops new antimicrobial compounds with novel chemical structures that can effectively target resistant bacteria. These new compounds represent fresh therapeutic options that can overcome existing resistance mechanisms, similar to how disposable items provide fresh solutions without carrying forward previous failures
Solution Approach 2:
The patent creates composite antimicrobial agents with specific molecular structures combining multiple functional groups (imidazole, pyridine, bromophenyl moieties) to achieve enhanced antimicrobial activity against resistant strains through synergistic interactions of different chemical groups
3Productivity
If traditional synthesis methods are used, then chemical reactions can proceed, but reaction times are longer and conditions are more severe, reducing process efficiency
Solution Approach 1:
The patent uses ionic liquids as intermediary substances that facilitate the chemical reaction under milder conditions. The ionic liquids act as mediators that lower the energy barrier for reaction, enabling faster reaction rates at lower temperatures compared to traditional methods
Data Source
AI summary
An 4,5-bis(4-bromophenyl)-1-hexyl-2-(3-pyridyl)-1H-imidazole compound, its synthesis, and its use as an antimicrobial agent.